ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of ...

For many, especially women, these scans are compelling. They offer agency in a healthcare system that often feels slow, ...

Surgeons were stunned when a routine brain biopsy revealed a living, 80mm predator thriving inside a patient’s frontal lobe.

Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...

Overview of secondary liver cancer care pathways, key treatment steps, and the situations where dendritic cell treatment may be discussed as a selected option.

Tech tycoons, podcast bros and Hollywood stars are all piling money into full-body scans, which deploy AI in the hope of catching everything from high cholesterol to cancer. Is this the first step to ...

Researchers at Tezpur University in India have identified a panel of circulating microRNAs in blood serum that may help distinguish gallbladder cancer from benign conditions, offering a potential ...

Fujifilm Healthcare Europe will present the new Arietta DeepInsight x ultrasound technology platforms at the House of Fujifilm experience at ECR 2026: Rays of Knowledge.

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...

ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency ...